CN1065529C - 4－喹啉酮衍生物及其盐 - Google Patents

4－喹啉酮衍生物及其盐 Download PDF

Info

Publication number
CN1065529C
CN1065529C CN95193500A CN95193500A CN1065529C CN 1065529 C CN1065529 C CN 1065529C CN 95193500 A CN95193500 A CN 95193500A CN 95193500 A CN95193500 A CN 95193500A CN 1065529 C CN1065529 C CN 1065529C
Authority
CN
China
Prior art keywords
carbon atom
salt
alkyl
compound
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95193500A
Other languages
English (en)
Chinese (zh)
Other versions
CN1150420A (zh
Inventor
山崎和应
阿出川滋
小川阳一郎
松田秀明
仓石忠幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1150420A publication Critical patent/CN1150420A/zh
Application granted granted Critical
Publication of CN1065529C publication Critical patent/CN1065529C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN95193500A 1994-06-09 1995-06-06 4－喹啉酮衍生物及其盐 Expired - Fee Related CN1065529C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP127573/1994 1994-06-09
JP12757394 1994-06-09
JP127573/94 1994-06-09

Publications (2)

Publication Number Publication Date
CN1150420A CN1150420A (zh) 1997-05-21
CN1065529C true CN1065529C (zh) 2001-05-09

Family

ID=14963397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95193500A Expired - Fee Related CN1065529C (zh) 1994-06-09 1995-06-06 4－喹啉酮衍生物及其盐

Country Status (8)

Country Link
US (1) US5789419A (OSRAM)
EP (1) EP0764639A4 (OSRAM)
JP (1) JP3662929B2 (OSRAM)
KR (1) KR100254106B1 (OSRAM)
CN (1) CN1065529C (OSRAM)
CA (1) CA2191245A1 (OSRAM)
TW (1) TW308587B (OSRAM)
WO (1) WO1995033726A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605597B1 (en) * 1999-12-03 2003-08-12 Cv Therapeutics, Inc. Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
US6294522B1 (en) 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
CN103108868B (zh) 2010-06-07 2015-11-25 诺沃梅迪科斯有限公司 呋喃基化合物及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298452A2 (de) * 1987-07-06 1989-01-11 F. Hoffmann-La Roche Ag In 4-Stellung durch Aryl oder N-Heteroaryl substituierte 2H-1-Benzopyran-Derivate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
JPS61165760A (ja) * 1985-01-17 1986-07-26 Canon Inc 電子写真感光体
GB8916683D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel compounds
TW224941B (OSRAM) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298452A2 (de) * 1987-07-06 1989-01-11 F. Hoffmann-La Roche Ag In 4-Stellung durch Aryl oder N-Heteroaryl substituierte 2H-1-Benzopyran-Derivate

Also Published As

Publication number Publication date
EP0764639A1 (en) 1997-03-26
EP0764639A4 (en) 1997-10-01
TW308587B (OSRAM) 1997-06-21
KR100254106B1 (ko) 2000-05-01
CA2191245A1 (en) 1995-12-14
KR970703316A (ko) 1997-07-03
WO1995033726A1 (fr) 1995-12-14
US5789419A (en) 1998-08-04
JP3662929B2 (ja) 2005-06-22
CN1150420A (zh) 1997-05-21

Similar Documents

Publication Publication Date Title
EP1133474B1 (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
KR100628013B1 (ko) 트리시클릭 락탐 및 술탐 유도체, 및 히스톤 디아세틸라제억제제로서 이들의 용도
RU2155187C2 (ru) Производные индола, их таутомеры, смеси их изомеров или отдельные изомеры и фармацевтически приемлемые соли, фармацевтическая композиция с антиопухолевой или ингибирующей протеин-тирозинкиназу активностью и способ торможения зависящего от протеин-тирозинкиназы заболевания или борьбы с аберрантным ростом клеток млекопитающего или человека.
EP1919869B1 (fr) Dérivés de l'indole activateurs des ppar
EP3921317B1 (en) 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as csnk1 inhibitors
WO2007075872A2 (en) Nitroimidazole compounds
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
EP3057951B1 (en) Methylene linked quinolinyl modulators of ror-gamma-t
JP2005522452A (ja) Ｃｎｓ疾患の治療のための、５−ｈｔ６受容体アフィニティーを有する７−アリールスルホンアミド−２，３，４，５−テトラヒドロ−１ｈ−ベンゾ’ジアゼピン誘導体
RU2162470C2 (ru) 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения
CN1323308A (zh) 新的化合物
HU204517B (en) Process for producing new 1,4-benzoxazine derivatives and pharmaceutical compositions containing them
EA012461B1 (ru) Соединения, обладающие антимикобактериальной активностью
CN1065529C (zh) 4－喹啉酮衍生物及其盐
CN101341150A (zh) 硝基咪唑化合物
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
KR20120036840A (ko) １?（２?알킬?２，３?디하이드로?벤조푸란?４?일）?피롤리딘?３?일아민 아실 화합물
CN1081442A (zh) 苯并二氮杂䓬
US5500442A (en) Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
KR20050102081A (ko) 3-치환된-4-아릴퀴놀린-2-온 유도체의 아트로프 이성체
JPS6219583A (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPH09176166A (ja) ビス−アザ−二環式抗不安薬の製法
CN1011588B (zh) 吡啶衍生物的制备方法
JPH0631217B2 (ja) 二環式パーオキサイド
JPH0522706B2 (OSRAM)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
FG4A Grant of patent
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee